This inventor holds 2 USPTO granted patents and 9 published patent applications. Top assignee: Biothera Inc.. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Innovations by Ross Fulton
Introduction
Ross Fulton is an accomplished inventor based in Saint Paul, MN (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 2 patents, his work focuses on enhancing the effectiveness of anti-cancer agents.
Latest Patents
Fulton's latest patents include methods and compositions involving soluble β-glucan that affect the tumor microenvironment. The first patent discusses the combination of soluble β-glucan and immune suppression-relieving agents, which promotes an immunostimulatory environment. This environment enhances the effectiveness of anti-angiogenics and checkpoint inhibitors, including non-tumor targeting antibodies. His second patent relates to the combination of soluble β-glucan and anti-cancer agents, which also aims to improve the tumor microenvironment and boost the effectiveness of these agents.
Career Highlights
Ross Fulton is currently associated with Biothera Inc., where he continues to innovate in the field of cancer research. His work has been pivotal in developing new therapeutic strategies that leverage the immune system to combat cancer.
Collaborations
Some of his notable coworkers include Kathryn A Fraser and Nadine Ottoson, who contribute to the collaborative efforts at Biothera Inc. Their combined expertise enhances the research and development initiatives within the company.
Conclusion
Ross Fulton is a notable inventor whose work in cancer treatment through innovative methods and compositions has the potential to significantly impact patient outcomes. His contributions to the field are commendable and reflect his dedication to advancing medical science.